133 related articles for article (PubMed ID: 17928740)
1. Lifestyle-related diseases of the digestive system: a new in vitro model of hepatitis C virion production: application of basic research on hepatitis C virus to clinical medicine.
Saito S; Heller T; Yoneda M; Takahashi H; Nakajima A; Liang JT
J Pharmacol Sci; 2007 Oct; 105(2):138-44. PubMed ID: 17928740
[TBL] [Abstract][Full Text] [Related]
2. An in vitro model of hepatitis C virion production.
Heller T; Saito S; Auerbach J; Williams T; Moreen TR; Jazwinski A; Cruz B; Jeurkar N; Sapp R; Luo G; Liang TJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2579-83. PubMed ID: 15701697
[TBL] [Abstract][Full Text] [Related]
3. [Production of infectious hepatitis C virus in cell culture].
Kato T; Wakita T
Uirusu; 2005 Dec; 55(2):287-95. PubMed ID: 16557015
[TBL] [Abstract][Full Text] [Related]
4. A primer on the molecular virology of hepatitis C.
Moradpour D; Blum HE
Liver Int; 2004 Dec; 24(6):519-25. PubMed ID: 15566499
[TBL] [Abstract][Full Text] [Related]
5. Novel chimeric genotype 1b/2a hepatitis C virus suitable for high-throughput screening.
Zhang Y; Weady P; Duggal R; Hao W
Antimicrob Agents Chemother; 2008 Feb; 52(2):666-74. PubMed ID: 18039917
[TBL] [Abstract][Full Text] [Related]
6. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
[TBL] [Abstract][Full Text] [Related]
7. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
8. Experimental models for hepatitis C virus (HCV): new opportunities for combating hepatitis C.
Trujillo-Murillo Kdel C; Garza-Rodríguez Mdel L; Martínez-Rodríguez HG; Barrera-Saldaña HA; Bosques-Padilla F; Ramos-Jiménez J; Rivas-Estilla AM
Ann Hepatol; 2004; 3(2):54-62. PubMed ID: 15257247
[TBL] [Abstract][Full Text] [Related]
9. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
[TBL] [Abstract][Full Text] [Related]
10. Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.
Horscroft N; Lai VC; Cheney W; Yao N; Wu JZ; Hong Z; Zhong W
Antivir Chem Chemother; 2005; 16(1):1-12. PubMed ID: 15739617
[TBL] [Abstract][Full Text] [Related]
11. Production of infectious hepatitis C virus of various genotypes in cell cultures.
Kato T; Matsumura T; Heller T; Saito S; Sapp RK; Murthy K; Wakita T; Liang TJ
J Virol; 2007 May; 81(9):4405-11. PubMed ID: 17301131
[TBL] [Abstract][Full Text] [Related]
12. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
[TBL] [Abstract][Full Text] [Related]
13. In vitro replication models for the hepatitis C virus.
Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
[TBL] [Abstract][Full Text] [Related]
14. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
15. Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.
Masaki T; Suzuki R; Saeed M; Mori K; Matsuda M; Aizaki H; Ishii K; Maki N; Miyamura T; Matsuura Y; Wakita T; Suzuki T
J Virol; 2010 Jun; 84(11):5824-35. PubMed ID: 20237083
[TBL] [Abstract][Full Text] [Related]
16. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
[TBL] [Abstract][Full Text] [Related]
17. HCV research and anti-HCV drug discovery: toward the next generation.
Wakita T
Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
[TBL] [Abstract][Full Text] [Related]
18. A compartmentalization model of hepatitis C virus replication: an appropriate distribution of HCV RNA for the effective replication.
Nakabayashi J
J Theor Biol; 2012 May; 300():110-7. PubMed ID: 22286015
[TBL] [Abstract][Full Text] [Related]
19. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
Bukh J
J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
[TBL] [Abstract][Full Text] [Related]
20. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
